典型文献
Effectiveness and safety of Ginkgo biloba extract(GBE50)in the treatment of dizziness caused by cerebral arteriosclerosis:a multi-center,double-blind,randomized controlled trial
文献摘要：
OBJECTIVE:To evaluate the effectiveness and safety of Ginkgo biloba extract(GBE50)in the treatment of dizziness caused by cerebral arteriosclerosis.METHODS:This was a multi-center,double-blind,double-dummy,positive-controlled,parallel randomized controlled clinical trial with 1:1 allocation.We recruited 404 patients with dizziness caused by cerebral arteriosclerosis(blood stasis symptom pattern)in 10 hospitals in China.GBE50 group received GBE50 and Naoxinqing tablet(NXQ)of mimetic agent,control group received NXQ and GBE50 of mimetic agent.The main outcome was Traditional Chinese Medicine(TCM)symptom pattern score of blood stasis after 6 weeks.The secondary outcomes were changes in the dizziness handicap inventory(DHI)score,vertigo visual analogue scale(VAS)score,the university of California vertigo questionnaire(UCLA-DQ)score and single-item symptom score of TCM from baseline to 2,4 and 6 weeks.Safety indicators included the incidence of adverse events,severe adverse events and laboratory examination including blood routine,liver function,renal function,and so forth.RESULTS:The total effective rate of TCM symptom pattern score in the GBE50 group after 6 weeks of treatment was higher than that in the control group,the difference in rate was statistically significant(92.67％vs 83.07％,P=0.004).Compared with the control group,there was no difference in the incidence of adverse reactions(9.95％vs 14.85％,P=0.136).CONCLUSION:The treatment of dizziness caused by cerebral arteriosclerosis with GBE50 is effective,safe and reliable.
文献关键词：
中图分类号：
作者姓名：
SHA Rina;TANG Lu;DU Yawei;WU Shengxian;SHI Huawei;ZOU Hongxin;ZHANG Xuran;DONG Xinglu;ZHOU Li
作者机构：
the First clinical medical college,Beijing University of Chinese Medicine,Beijing 100029,China;Department of Neurology,Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China
文献出处：
引用格式：
[1]SHA Rina;TANG Lu;DU Yawei;WU Shengxian;SHI Huawei;ZOU Hongxin;ZHANG Xuran;DONG Xinglu;ZHOU Li-.Effectiveness and safety of Ginkgo biloba extract(GBE50)in the treatment of dizziness caused by cerebral arteriosclerosis:a multi-center,double-blind,randomized controlled trial)[J].中医杂志（英文版）,2022(01):83-89
A类：
GBE50,Naoxinqing,NXQ
B类：
Effectiveness,safety,Ginkgo,biloba,extract,treatment,dizziness,caused,by,cerebral,arteriosclerosis,multi,center,double,blind,randomized,controlled,trial,OBJECTIVE,To,evaluate,effectiveness,METHODS,This,was,dummy,positive,parallel,clinical,allocation,We,recruited,patients,blood,stasis,symptom,pattern,hospitals,China,group,received,tablet,mimetic,agent,main,Traditional,Chinese,Medicine,TCM,score,after,weeks,secondary,outcomes,were,changes,handicap,inventory,DHI,vertigo,visual,analogue,scale,VAS,university,California,questionnaire,UCLA,DQ,single,item,from,baseline,Safety,indicators,included,incidence,adverse,events,severe,laboratory,examination,including,routine,liver,function,renal,so,forth,RESULTS,total,rate,higher,than,that,difference,statistically,significant,Compared,there,no,reactions,CONCLUSION,reliable
AB值：
0.475681
相似文献
机标中图分类号，由域田数据科技根据网络公开资料自动分析生成，仅供学习研究参考。
